• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

20.9% Growth in Car T Cell Therapy Market by 2022-2030 | Company Profiles, Top Regions, Latest Technology, Investment Opportunities, Future Trends | Sales, Price, Revenue, Gross Margin, Cost Analysis

February 24th, 2023 Coherent Market Insights Releases

Car T Cell Therapy Market Analysis

CAR T Cell Therapy Market, By Targeted Antigen (HER1, HER2, GD2, BCMA,CD20, CD19, CD22, CD30, CD33, Others (CLDN18, etc.)), By Therapeutic Application (Chronic Lymphocytic Leukemia, Acute Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma (DLBCL), Mantle Cell Lymphoma, Follicular Lymphoma, Glioblastoma, Multiple Myeloma, Hepatocellular Carcinoma, Sarcoma, Acute Myeloid Leukemia, Neuroblastoma, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (Africa, Latin America, Asia Pacific, the Middle East, Europe, North America) – Size, Outlook, Share, and Opportunity Analysis, 2022–2030

Request a sample copy of this report @ Click here: – https://www.coherentmarketinsights.com/insight/request-sample/102

Chimeric antigen receptor—T, i.e., CAR T cell therapy, is a form of gene cell therapy that utilizes T cells to attack cancer cells. The process involves three main stages, including collecting T cells, modifying them through engineering, and then introducing the CAR T cells back into the body. This approach is T-cell immunotherapy, which harnesses the body’s own immune system to combat cancer. A significant risk associated with CAR T cell therapy is cytokine release syndrome (CRS), which occurs when CAR T cells release cytokines, triggering immune responses such as fever, fatigue, diarrhea, chills, nausea, difficulty breathing, low blood pressure, and other symptoms.

The global CAR T cell therapy market is projected to reach a value of US$ 2,259.5 million by 2022 growing at a CAGR of 20.9 % during the forecast period from 2022 to 2030.

Market Drivers

The global CAR T cell therapy market is anticipated to experience growth during the forecast period due to the rising incidence of cancer. As an illustration, in February 2022, the World Health Organization (WHO) released a fact sheet indicating that approximately 400,000 children are diagnosed with cancer every year and there were 2.26 million cases of breast cancer worldwide in 2021.

During the forecast period, the global CAR T cell therapy market is anticipated to experience growth due to major companies prioritizing product approval. For example, in April 2022, Kite Pharma, Inc., which is a subsidiary of Gilead Sciences, Inc. and a research-based biopharmaceutical company focused on developing innovative medicines, received approval from the U.S. Food and Drug Administration for Yescarta as an initial treatment for relapsed or refractory large B-cell lymphoma (LBCL).

Impact of the Coronavirus (COVID-19) Pandemic

The disease caused by the COVID-19 virus has spread to more than 100 countries worldwide since it first emerged in December 2019, and on January 30, 2020, the World Health Organization declared it a public health emergency.

The economy has been impacted by COVID-19 in three major ways, including the direct influence on drug and vaccine production and demand, the disruptions caused in distribution channels, and the financial repercussions on firms and financial markets. Countries including India, Egypt, Saudi Arabia, China, the U.A.E., and others experienced challenges in transporting vaccines and drugs due to nationwide lockdowns. Since the emergence of the COVID-19 pandemic in December 2019, it has rapidly spread to over 100 countries, leading the World Health Organization to declare it a public health emergency. As of November 15, 2022, a report published by the World Health Organization indicates that COVID-19 has caused more than 632,533,408 confirmed cases worldwide.

Additionally, cancer patients are greatly affected by the COVID-19 pandemic as it pertains to the implementation of CAR T cell therapy for SARS-CoV-2. In April 2020, Duke-NUS, a school of the National University of Singapore, released data which suggested that CAR T cell therapy could be utilized for the management of SARS-CoV-2 and other infectious diseases.

Buy Now, Getting Exclusive (Up To 45% Discount) click here @ https://www.coherentmarketinsights.com/promo/buynow/102

Recent Developments

Bristol-Myers Squibb Company, a prominent biopharmaceutical company, received US Food and Drug Administration approval for Breyanzi CAR T cell therapy in June 2022. This therapy is intended for treating large B-cell lymphoma in patients who have experienced relapse or have not responded to prior treatment. The approval was granted after the Phase 2 pilot company-sponsored study, which evaluated the effectiveness of CAR T cell therapy in patients with primary refractory or relapsed LBCL.

CARVYKTI (ciltacabtagene autoleucel), a BCMA-directed CAR T immunotherapy for treating patients with relapsed or refractory multiple myeloma, was approved by the US Food and Drug Administration in February 2022. This breakthrough was announced by Johnson & Johnson Services, Inc., which is one of the biggest healthcare companies.

Market Restraints

The primary obstacle to the expansion of the global CAR T cell therapy market is the adverse effects of this treatment. In March 2022, the American Cancer Society, a nationwide voluntary health organization, released data indicating that numerous potential side effects may arise from CAR T cell therapy, including high fever, respiratory difficulties, chills, vomiting, severe nausea, diarrhea, dizziness or lightheadedness, rapid heartbeat, headaches, fatigue, as well as muscle and joint pain.

Major Companies

Some of the major companies in the global CAR T cell therapy market consist of Sorrento Therapeutics, Inc., Pfizer Inc., Bristol-Myers Squibb Company, Fate Therapeutics, Johnson & Johnson Services Inc., Bluebird Bio, Inc., Novartis AG, Gilead Sciences, Inc., CARsgen Therapeutics Co., Ltd., Legend Biotech, Mustang Bio, and Aurora Biopharma.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Targeted Antigen
      • Market Snapshot, By Therapeutic Application
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Regulatory Scenario
    • Pipeline Analysis
    • PEST Analysis
    • Porter’s Analysis

Get your Customized Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/102

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬

Plasmid dna manufacturing market

Bovine plasma market 

Gmp protein e coli contract manufacturing market

Cell therapy market

Mrna synthesis service market 

Recombinant protein market

Stem cell manufacturing market 

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah

Coherent Market Insights Pvt Ltd,

533 Airport Boulevard, Suite 400, Burlingame

CA 94010, United States

Email: sales@coherentmarketinsights.com

Phone: U.S.: +1-206-701-6702

U.K.: +44-020-8133-4027

JAPAN: +81-50-5539-1737

INDIA: +91-848-285-0837

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email